In the last trading session, 1.09 million shares of the Ekso Bionics Holdings Inc (NASDAQ:EKSO) were traded, and its beta was 1.48. Most recently the company’s share price was $0.63, and it changed around -$0.02 or -2.84% from the last close, which brings the market valuation of the company to $13.92M. EKSO currently trades at a discount to its 52-week high of $2.50, offering almost -296.83% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 20.63% since then. We note from Ekso Bionics Holdings Inc’s average daily trading volume that its 10-day average is 5.57 million shares, with the 3-month average coming to 1.01 million.
Ekso Bionics Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended EKSO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Ekso Bionics Holdings Inc (NASDAQ:EKSO) trade information
Instantly EKSO has showed a red trend with a performance of -2.84% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7396 on recent trading dayincreased the stock’s daily price by 14.82%. The company’s shares are currently up 3.77% year-to-date, but still down -11.11% over the last five days. On the other hand, Ekso Bionics Holdings Inc (NASDAQ:EKSO) is -11.72% down in the 30-day period. We can see from the shorts that 0.24 million shares have been sold at a short interest cover period of 1.41 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 68.5% from its current value. Analyst projections state that EKSO is forecast to be at a low of $2 and a high of $2.
Ekso Bionics Holdings Inc (EKSO) estimates and forecasts
Ekso Bionics Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -48.11 percent over the past six months and at a 56.36% annual growth rate that is well above the industry average of 15.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 30.19%.
EKSO Dividends
Ekso Bionics Holdings Inc’s next quarterly earnings report is expected to be released in February.
Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 7.91% of Ekso Bionics Holdings Inc shares, and 25.25% of them are in the hands of institutional investors. The stock currently has a share float of 27.42%. Ekso Bionics Holdings Inc stock is held by 30.0 institutions, with KENT LAKE CAPITAL LLC being the largest institutional investor. By 2024-06-30, it held 3.9959% of the shares, which is about 0.7 million shares worth $0.73 million.
VANGUARD GROUP INC, with 3.4125% or 0.59 million shares worth $0.63 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
